Smoking and higher mortality in men

December 04, 2014

In a new study, published in Science, researchers at Uppsala University demonstrate an association between smoking and loss of the Y chromosome in blood cells. The researchers have previously shown that loss of the Y chromosome is linked to cancer. Since only men have the Y chromosome, these results might explain why smoking is a greater risk factor for cancer among men and, in the broader perspective, also why men in general have a shorter life expectancy.

Smoking is a risk factor for various diseases, not only lung cancer. Epidemiological data show that male smokers have a greater risk of developing cancer outside the respiratory tract than female smokers. In the present study, which is the result of an international collaboration, the researchers discovered an association between smoking and genetic damage among men that might explain this sex difference.

'We have previously in 2014 demonstrated an association between loss of the Y chromosome in blood and greater risk for cancer. We now tested if there were any lifestyle- or clinical factors that could be linked to loss of the Y chromosome. Out of a large number of factors that were studied, such as age, blood pressure, diabetes, alcohol intake and smoking, we found that loss of the Y chromosome in a fraction of the blood cells was more common in smokers than in non-smokers', says Lars Forsberg, researcher at the Department of Immunology, Genetics and Pathology, Uppsala University, and responsible for the study.

The association between smoking and loss of the Y chromosome was dose dependent, i.e. loss of the Y chromosome was more common in heavy smokers compared to moderate smokers. In addition, the association was only valid for men who were current smokers. Men who had been smoking previously, but quit, showed the same frequency of cells with loss of the Y chromosome, as men who had never smoked.

'These results indicate that smoking can cause loss of the Y chromosome and that this process might be reversible. We found that the frequency of cells with loss of the Y chromosome was not different among ex-smokers compared to men who had never smoked. This discovery could be very persuasive for motivating smokers to quit', says Lars Forsberg.

How loss of the Y chromosome in blood cells, induced by smoking, is connected with the development of cancer throughout the body is still not clear. One possibility is that immune cells in blood, that have lost their Y chromosome, have a reduced capacity to fight cancer cells.

'In summary, we have shown that there is a correlation between a common and avoidable risk factor, that is smoking, and the most common human mutation, loss of the Y chromosome. This finding may in part explain why men in general have a shorter life span than women, and why smoking is more dangerous for men', says Jan Dumanski, professor at the same department of Uppsala University, who has had a leading role in the study.
-end-
The study is a collaboration between researchers at Uppsala University, Södertörn University, Karolinska Institutet, the University of Oxford, Broad Institute of MIT and Harvard University, the University of Liverpool, New York University and Stockholm School of Economics. The results have been published on-line in Science Express.

For more information please contact:

Lars Forsberg; lars.forsberg@igp.uu.se, office: +46 18 471 4839,
cell phone: +46 70 740 1775

Jan Dumanski; jan.dumanski@igp.uu.se, office: +46 18 471 5035,
cell phone: +46 70 4250616

Article:

Smoking Is Associated with Mosaic Loss of Chromosome Y. Jan Dumanski et al., Science Dec 4 2014

Previously this year the same investigators published an association between loss of the Y chromosome and mortality as well as risk for cancer in men in Nature Genetics. See previous press release: http://www.uu.se/en/media/press-release-document/?id=2297&area=3,8&typ=pm&na=&lang=en

Link to the Nature Genetics article: http://www.nature.com/ng/journal/v46/n6/full/ng.2966.html

The researchers above are affiliated to Science for Life Laboratory (SciLifeLab). SciLifeLab is a Swedish national centre for molecular biosciences with the focus on health and environmental research. The centre combines advanced technical know-how and state-of-the art equipment with a broad knowledge of translational medicine and molecular bioscience.

Uppsala University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.